drugset / Trial / NCT00451490

The Effect of Agomelatine or Fluoxentine on Heart Rate Variability in Patients With Major Depressive Disorder

NCT00451490 ↗

Withdrawn 24 enrolled National Taiwan University Hospital
RandomizedParallel-groupDouble-blindHealth-services research

Summary

Phase advance of HRV will be anticipated in agomelatine group. It is anticipated that both agomelatine and floxentine will increase HRV at the end of the treatment.

Timeline

Start
2006-10
Primary completion
—
Completion
2007-12

Outcome

Outcome not reported

Stopped: “This study not get the approval by the drug company”

Drugs

EvaluationDrugModalityDoseRoute
Subject Agomelatine Small molecule — —
Subject Fluoxentine Unknown — —